Survival and causes of death among people with clinically diagnosed dementia with Lewy bodies: A multicenter cohort study

医学 路易氏体型失智症 痴呆 内科学 比例危险模型 死因 生存分析 队列 临床痴呆评级 儿科 疾病
作者
Meimei Zuo,Wenjie Yue,Ding Zhang,Shuai Liu,Jinghuan Gan,Xiaodan Wang,Hao Wu,Yong Ji
出处
期刊:International Journal of Geriatric Psychiatry [Wiley]
卷期号:37 (11) 被引量:3
标识
DOI:10.1002/gps.5826
摘要

A comprehensive study of the survival and causes of death of people with clinically diagnosed Dementia with Lewy bodies (DLB) were few. The aim of our study was to investigate the survival and causes of death of DLB.The patients diagnosed with probable DLB were consecutively enrolled from five memory clinics in China across a 5-year period (2017-2021) with mortality data updated to December 2021. The endpoint was all-cause death. Survival analysis including Cox regression by groups (time both from disease onset and the first visit to death) and causes of death were evaluated.Of the 108 patients with DLB, 54 (50%) were men and the time from onset of disease to the first visit to the memory clinic (lag time) was 24 (12-48) months. During follow-up, 28.7% (n = 31) of the patients died. The median survival time both from disease onset and the first visit were 81 (95% cognitive impairment (CI) 69.09-92.91) and 45 (95% CI 34.78-55.22) months, respectively. The use of antipsychotic drugs (HR 0.15, 95% CI: 0.03-0.75), moderate to severe dementia (Clinical Dementia Rating [CDR]) at the first visit (HR 0.22, 95% CI 0.78 to 0.62) and the longer lag time (HR 0.943, 95% CI 0.92-0.97) predicted a shorter survival. Failure to thrive (stopped eating, drinking) or multiple organ dysfunction syndrome (MODS) maybe the most common cause of death (41.7%), followed by pneumonia or aspiration (29.2%).The factors associated with survival time were disease severity level, antipsychotic drug use and lag time to seek medical advice. Failure to thrive or MODS and pneumonia were probably the most common cause of death. The long-term outcomes of DLB patients may be helpful to guide clinicians counseling patients and caregivers.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Ava应助长歌采纳,获得10
刚刚
冰淇淋完成签到,获得积分10
1秒前
大胆一刀发布了新的文献求助10
2秒前
刘玉欣发布了新的文献求助10
2秒前
2秒前
微笑凡之完成签到,获得积分10
2秒前
弄井完成签到,获得积分10
5秒前
橘园完成签到 ,获得积分10
6秒前
科研通AI2S应助Cheng采纳,获得10
6秒前
8秒前
烟花应助科研通管家采纳,获得10
11秒前
ccm应助科研通管家采纳,获得150
11秒前
GPTea应助科研通管家采纳,获得150
11秒前
丘比特应助科研通管家采纳,获得10
11秒前
星辰大海应助科研通管家采纳,获得10
11秒前
Ava应助科研通管家采纳,获得10
11秒前
炼丹师应助科研通管家采纳,获得20
11秒前
Tourist应助科研通管家采纳,获得10
12秒前
科研通AI6应助科研通管家采纳,获得10
12秒前
12秒前
科研通AI5应助科研通管家采纳,获得10
12秒前
12秒前
科目三应助科研通管家采纳,获得10
12秒前
一叶知秋应助科研通管家采纳,获得10
12秒前
ccm应助科研通管家采纳,获得10
12秒前
科研通AI5应助科研通管家采纳,获得10
12秒前
慕青应助科研通管家采纳,获得10
12秒前
12秒前
12秒前
情怀应助科研通管家采纳,获得30
12秒前
李爱国应助科研通管家采纳,获得10
13秒前
传奇3应助科研通管家采纳,获得30
13秒前
13秒前
一叶知秋应助科研通管家采纳,获得10
13秒前
打打应助科研通管家采纳,获得10
13秒前
李健应助科研通管家采纳,获得10
13秒前
英俊的铭应助科研通管家采纳,获得10
13秒前
传奇3应助科研通管家采纳,获得10
13秒前
李爱国应助科研通管家采纳,获得10
13秒前
科研通AI6应助科研通管家采纳,获得10
13秒前
高分求助中
Comprehensive Toxicology Fourth Edition 24000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Pipeline and riser loss of containment 2001 - 2020 (PARLOC 2020) 1000
World Nuclear Fuel Report: Global Scenarios for Demand and Supply Availability 2025-2040 800
Handbook of Social and Emotional Learning 800
Risankizumab Versus Ustekinumab For Patients with Moderate to Severe Crohn's Disease: Results from the Phase 3B SEQUENCE Study 600
Lloyd's Register of Shipping's Approach to the Control of Incidents of Brittle Fracture in Ship Structures 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5134322
求助须知:如何正确求助?哪些是违规求助? 4335087
关于积分的说明 13505951
捐赠科研通 4172482
什么是DOI,文献DOI怎么找? 2287697
邀请新用户注册赠送积分活动 1288658
关于科研通互助平台的介绍 1229444